Dymon Asia Capital (Singapore)’s CVS Health CVS Stock Holding History

Dymon Asia Capital (Singapore)’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-50,000	Closed	-$3.45M	–	267
2025 Q2	$3.45M	Sell	50,000 -20,000	-29%	-$1.31M	0.48%	40
2025 Q1	$4.74M	Buy	+70,000	New	+$4.19M	1.06%	25
2024 Q4	–	Sell	-57,500	Closed	-$3.62M	–	115
2024 Q3	$3.62M	Sell	57,500 -50,000	-47%	-$2.92M	0.98%	33
2024 Q2	$6.35M	Buy	107,500 +57,500	+115%	+$3.6M	1.69%	16
2024 Q1	$3.99M	Buy	+50,000	New	+$3.82M	0.88%	35
2021 Q1	–	Sell	-50,000	Closed	-$3.42M	–	143
2020 Q4	$3.42M	Buy	+50,000	New	+$3.25M	0.75%	40

Other funds holding CVS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Dymon Asia Capital (Singapore)'s CVS Position: Q3 2024 in Review

Dymon Asia Capital (Singapore) sold out of CVS Health (CVS) in Q3 2024, closing a stake of 21,727 shares — an estimated $1.27M sold.

Dymon Asia Capital (Singapore) first reported a position in CVS in Q4 2020 and held it in 2 quarters. The position peaked at $1.28M in Q2 2024. 1,842 funds tracked by Wall St. Rank hold CVS as of Q3 2024.

Dymon Asia Capital (Singapore) reported no remaining CVS Health position as of Q3 2024 after selling out during the quarter.
Dymon Asia Capital (Singapore) sold 21,727 CVS Health shares in Q3 2024, an estimated $1.27M.
Dymon Asia Capital (Singapore) first reported a position in CVS Health in Q4 2020 and held it in 2 quarters.
Dymon Asia Capital (Singapore)'s CVS Health position peaked at $1.28M in Q2 2024.
1,842 funds tracked by Wall St. Rank held CVS Health as of Q3 2024.

Based on Dymon Asia Capital (Singapore)'s 13F filing for Q3 2024, filed 12 Nov 2024.